KLK5 and ovarian cancer: While little is known about the biological basis for the contribution of KLK5, 6 and 10 to ovarian cancer, the ability of KLK5 and 6 to cleave ECM proteins [4], [29], and activate PAR signaling [30], suggest that they are directly implicated in various aspects of carcinogenesis.